284 related articles for article (PubMed ID: 31301562)
1. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
[TBL] [Abstract][Full Text] [Related]
2. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
[TBL] [Abstract][Full Text] [Related]
3. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
4. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
5. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.
De Felice FG; Velasco PT; Lambert MP; Viola K; Fernandez SJ; Ferreira ST; Klein WL
J Biol Chem; 2007 Apr; 282(15):11590-601. PubMed ID: 17308309
[TBL] [Abstract][Full Text] [Related]
6. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways.
Song G; Li Y; Lin L; Cao Y
Mol Med Rep; 2015 Nov; 12(5):7615-22. PubMed ID: 26459718
[TBL] [Abstract][Full Text] [Related]
7. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against Aβ(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals.
Chen TF; Tang MC; Chou CH; Chiu MJ; Huang RF
Food Chem Toxicol; 2013 Dec; 62():538-47. PubMed ID: 24055771
[TBL] [Abstract][Full Text] [Related]
10. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral.
Rush T; Buisson A
Cell Tissue Res; 2014 May; 356(2):279-86. PubMed ID: 24496511
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
Danysz W; Parsons CG
Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review.
Phadke AV; Tayade AA; Khambete MP
Chem Biol Drug Des; 2021 Nov; 98(5):713-721. PubMed ID: 34240555
[TBL] [Abstract][Full Text] [Related]
14. Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss.
Birnbaum JH; Bali J; Rajendran L; Nitsch RM; Tackenberg C
Cell Death Dis; 2015 Jun; 6(6):e1791. PubMed ID: 26086964
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
18. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
[TBL] [Abstract][Full Text] [Related]
19. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
Rogawski MA; Wenk GL
CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
[TBL] [Abstract][Full Text] [Related]
20. Synthetic analogues of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies.
Tencheva A; Liu R; Volkova TV; Chayrov R; Mitrev Y; Štícha M; Li Y; Jiang H; Li Z; Stankova I; Perlovich GL
Amino Acids; 2020 Dec; 52(11-12):1559-1580. PubMed ID: 33191465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]